a Department of Pharmacology and Toxicology , Bombay College of Pharmacy , Kalina , Mumbai , 400 098 , India.
b Department of Pharmaceutical Sciences and Technology , Institute of Chemical Technology , Matunga , Mumbai , 400 019 , India.
Drug Dev Ind Pharm. 2019 Feb;45(2):188-201. doi: 10.1080/03639045.2018.1539497. Epub 2018 Nov 27.
Transdermal route has been explored for various agents due to its advantage of bypassing the first pass effect and sustained release of drug. Due to strong barrier properties of the skin, mainly stratum corneum (SC), the delivery of many therapeutic agents across the skin has become challenging. Few drugs with specific physicochemical properties (molecular weight <500 Da, adequate lipophilicity, and low melting point) can be effectively administered via transdermal route. However, delivery of hydrophilic drugs and macromolecular agents including peptides, DNA and small interfering RNA is challenging. Drug penetration through the SC may involve bypass or reversible disruption of SC layer by various means. Recently, the use of micron-scale needles has been proposed in increasing skin permeability and shown to dramatically increase permeation, especially for macromolecules. Microneedles (MNs) can penetrate through the SC layer of the skin into the viable epidermis, avoiding contact with nerve fibers and blood vessels that reside primarily in the dermal layer. This review summarizes the types of MNs and fabrication techniques of different types of MNs. The safety aspects of the materials used for fabrication have been discussed in detail. Biological applications and relevant phase III clinical trials are also highlighted.
由于透皮给药具有绕过首过效应和药物持续释放的优势,因此已经探索了各种药物的透皮途径。由于皮肤,主要是角质层(SC)的强屏障特性,许多治疗剂的经皮传递变得具有挑战性。少数具有特定物理化学性质(分子量 <500 Da、足够的亲脂性和低熔点)的药物可以通过透皮途径有效给药。然而,亲水性药物和包括肽、DNA 和小干扰 RNA 在内的大分子药物的传递具有挑战性。药物通过 SC 的渗透可能涉及通过各种手段绕过或可逆地破坏 SC 层。最近,已经提出使用微米级针来增加皮肤通透性,并显示出可显著增加渗透,特别是对于大分子。微针(MN)可以穿透皮肤的 SC 层进入有活力的表皮,避免与主要存在于真皮层的神经纤维和血管接触。本综述总结了 MN 的类型和不同类型 MN 的制造技术。详细讨论了用于制造的材料的安全方面。还强调了生物学应用和相关的 III 期临床试验。
Drug Dev Ind Pharm. 2018-11-27
Curr Drug Targets. 2014-3
Recent Pat Drug Deliv Formul. 2011-1
Biomed Pharmacother. 2018-11-9
AAPS PharmSciTech. 2019-12-5
Drug Dev Ind Pharm. 2012-4-23
Expert Opin Drug Deliv. 2007-1
Expert Opin Drug Deliv. 2016
Micromachines (Basel). 2024-11-28
Biomed Eng Lett. 2024-3-29
Polymers (Basel). 2024-5-14
Drug Deliv Transl Res. 2024-6